Julita Kulbacka
Overview
Explore the profile of Julita Kulbacka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
206
Citations
2159
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rakoczy K, Szymanska N, Stecko J, Kisiel M, Sleziak J, Gajewska-Naryniecka A, et al.
Cells
. 2025 Mar;
14(5).
PMID: 40072059
Several molecular pathways are likely involved in the regulation of cancer stem cells (CSCs) via Ras-associated C3 botulinum toxin substrate 2, RAC2, and pituitary tumor-transforming gene 1 product, PTTG1, given...
2.
Kulbacka J, Novickij V
Expert Opin Drug Deliv
. 2025 Feb;
:1-5.
PMID: 39985482
No abstract available.
3.
Szewczyk A, Rembialkowska N, Saczko J, Daczewska M, Novickij V, Kulbacka J
Biol Res
. 2025 Feb;
58(1):10.
PMID: 39980072
Background: Electroporation (EP) leverages electric pulses to permeabilize cell membranes, enabling the delivery of therapeutic agents like calcium in cancer treatment. Calcium electroporation (CaEP) induces a rapid influx of calcium...
4.
Przystupski D, Rembialkowska N, Kulbacka J, Ussowicz M
Biomed Pharmacother
. 2025 Feb;
184:117877.
PMID: 39919462
Ultrasound-mediated sonoporation is a promising technique that temporarily permeabilizes cell membranes to enhance delivery of therapeutic agents directly to tumor sites while minimizing systemic side effects. Calcium, a critical regulator...
5.
Wezgowiec J, Lapinska Z, Lamch L, Szewczyk A, Saczko J, Kulbacka J, et al.
Int J Mol Sci
. 2025 Jan;
26(1.
PMID: 39795900
Due to the high mortality rate of ovarian cancer, there is a need to find novel strategies to improve current treatment modalities. Natural compounds offer great potential in this field...
6.
Rembialkowska N, Kulbacka J
Pharmaceuticals (Basel)
. 2025 Jan;
17(12.
PMID: 39770560
This Special Issue is dedicated to the memory of Professor Jolanta Saczko (1964-2023), a remarkable leader whose guidance and dedication were instrumental in advancing electroporation-based research in Poland [...].
7.
Bartoszewska E, Florek K, Zagorski K, Gachowska M, Wietrzyk A, Hutny A, et al.
Cells
. 2025 Jan;
13(24.
PMID: 39768186
Understanding morphological, biochemical, and functional aspects of cell death is essential for targeting new cancer therapies. Even though many different mechanisms of cell death are identified, it is crucial to...
8.
Radzka J, Gizak A, Drag-Zalesinska M, Haczkiewicz-Lesniak K, Kulus M, Szewczyk A, et al.
Front Cell Dev Biol
. 2025 Jan;
12:1476007.
PMID: 39763587
Introduction: NF-κB plays a pivotal role in the progression of cancers, including myosarcomas such as fibrosarcoma. Plants possess considerable potential for the provision of chemotherapeutic effects against cancer. The present...
9.
Kuznicki J, Janicka N, Bialynicka-Birula B, Kuznicki W, Chorazyczewska H, Deszcz I, et al.
Cells
. 2024 Dec;
13(23).
PMID: 39682696
Numerous studies have demonstrated the significant influence of immune cells on cancer development and treatment. This study specifically examines tumor-associated macrophages (TAMs), detailing their characteristics and roles in tumorigenesis and...
10.
Lapinska Z, Rembialkowska N, Szewczyk A, Przystupski D, Drag-Zalesinska M, Novickij V, et al.
Biomed Pharmacother
. 2024 Nov;
181:117708.
PMID: 39608316
Calcium electroporation (CaEP) is an efficient approach for ovarian cancer treatment. It causes cell death by introducing elevated levels of calcium into cells. In this work, the research focused on...